| 标题 |
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Juan P. Frías; Michael A. Nauck; Joanna Van; Mark E Kutner; Xuewei Cui; et al 出版日期:2018-10-04 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)